NASDAQ: AZRX
SEARCH
SIGN UP
About
Back
President's Message
Board of Directors
The Team
Science & Technology
Back
Overview
Programs
Development Pipeline
Cystic Fibrosis
Chronic Pancreatitis
Nosocomial Infections
Non-Systemic Biologics
Digestive Enzymes
Antibiotics and the Gut
Investors
Back
Press Releases
Back
2019
2018
2017
2016
2015
2014
Events
Back
Upcoming Events
Past Events
Presentation
Regulatory Filings
Financial Statements
Back
2019
Back
Q1 2019
2018
Back
Q4 2018
Q3 2018
Q2 2018
Q1 2018
2017
Back
Q4 2017
Q3 2017
Q2 2017
Q1 2017
2016
Back
Q4 2016
Q3 2016
Stock Info
Analyst Coverage
Corporate Governance
Contact Us
Clinical Studies
Back
Completed Clinical Studies
Clinical Publications
Collaborations
Back
Partnering with AzurRx
Contact
Back
Contact Us
Subscribe
Home
Investors
Press Releases
2014
Menu
Press Releases
2019
2018
2017
2016
2015
2014
Events
Upcoming Events
Past Events
Presentation
Regulatory Filings
Financial Statements
2019
Q1 2019
2018
Q4 2018
Q3 2018
Q2 2018
Q1 2018
2017
Q4 2017
Q3 2017
Q2 2017
Q1 2017
2016
Q4 2016
Q3 2016
Stock Info
Analyst Coverage
Corporate Governance
Contact Us
2014 News
Filters
Title Filter
Filter
List of articles in category 2014 News
Title
Date
AzurRx Announces Issuance of U.S. Patent for its MS1819 lipase compound
31 Jul, 2014
